Inventor · disambiguated record
Nobuko Nishimura
Also filed as: NISHIMURA NOBUKO
39 granted patents·11 pending applications·542 citations·filing 2002–2025
98Inventor score
Top patents by PatentIndex Score
50 records- 0198US11905281B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2020·Granted Feb 20, 2024·13 cites·16 claims
- 0298US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0398US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0498US10519146B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2018·Granted Dec 31, 2019·81 cites·33 claims
- 0598US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0697US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0797US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0897US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0997US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 1096US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 1196US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 1296US9611261B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Apr 4, 2017·25 cites·40 claims
- 1395US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 1495US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 1595US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1695US9085576B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Jul 21, 2015·31 cites·60 claims
- 1795US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 1893US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1991US7102009B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 5, 2006·49 cites·20 claims
- 2090US10150760B2Compounds for use in preparing heterocyclic triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Dec 11, 2018·8 cites·29 claims
- 2189US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 2288US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 2385US7101868B2Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Granted Sep 5, 2006·20 cites·36 claims
- 2484US2024174660A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2023·Application pending·0 cites
- 2580US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 2680US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 2780US7320992B2Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of useAMGEN INC·Filed 2004·Granted Jan 22, 2008·15 cites·38 claims
- 2877US8729074B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2010·Granted May 20, 2014·5 cites·2 claims
- 2975US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 3075US12441736B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·1 cites·31 claims
- 3174US10906890B2Triazole phenyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Feb 2, 2021·1 cites·20 claims
- 3273US11020395B2Cycloalkyl substituted triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 1, 2021·1 cites·26 claims
- 3370US8778941B2TRPM8 antagonists and their use in treatmentsBROWN JAMES·Filed 2012·Granted Jul 15, 2014·1 cites·33 claims
- 3470US8415376B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2009·Granted Apr 9, 2013·1 cites·9 claims
- 3570US7662811B21,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of useAMGEN INC·Filed 2005·Granted Feb 16, 2010·1 cites·13 claims
- 3670US2020055845A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2019·Application pending·0 cites
- 3769US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 3857US2005153960A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 3952US12435058B2KIF18A inhibitorsAMGEN INC·Filed 2020·Granted Oct 7, 2025·0 cites·21 claims
- 4052US2014235642A1Trpm8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Application pending·0 cites
- 4151US2003134836A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2002·Application pending·0 cites
- 4251US2022289724A1Kif18a inhibitorsAMGEN INC·Filed 2020·Application pending·0 cites
- 4350US7709501B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2006·Granted May 4, 2010·0 cites·10 claims
- 4450US2009082358A1Vanilloid receptor ligands and their use in treatmentsNISHIMURA NOBUKO·Filed 2008·Application pending·0 cites
- 4547US11191762B2Alkyl substituted triazole compounds as agonists of the APJ ReceptorAMGEN INC·Filed 2017·Granted Dec 7, 2021·0 cites·28 claims
- 4647US2015252011A1Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Application pending·0 cites
- 4746US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 4844US2006241296A1Vanilloid receptor ligands and their use in treatmentsDOHERTY ELIZABETH M·Filed 2006·Application pending·0 cites
- 4943US8476297B2TRP-M8 receptor ligands and their use in treatmentsNORMAN MARK H·Filed 2008·Granted Jul 2, 2013·0 cites·11 claims
- 5030US8431563B2Compounds that interact with glucokinase regulatory protein for the treatment of diabetesASHTON KATE·Filed 2011·Granted Apr 30, 2013·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Nobuko Nishimura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →